Friday, January 21, 2005


SKY MobileMedia Expands Board
San Diego-based SKY MobileMedia announced that it has added Rick Kornfeld, CEO fo Staccato Communications to its board of directors. The developer of mobile applications software platforms for wireless handsets said that the appointment will help accelerate the company's growing market momentum. Kornfeld also has served at Texas Instruments, Dot Wireless, NextWave, and Qualcomm.
posted on Friday, January 21, 2005(Full story)

SeeBeyond Targets Swedish Healthcare
Monrovia-based SeeBeyond and Swedish firm Cambio Healthcare Systems said this week that they've entered into a strategic alliance to market and deliver solutios to the Swedish government and healthcare sectors. Cambio, which develops patient management, order management, resource planning, e-prescription and statistical analysis systems, will use the SeeBeyond platform to create J2EE and Web services based solutions on service-oriented architecture (SOA).
posted on Friday, January 21, 2005(Full story)

Novatel Adds To Board
San Diego-based Novatel Wireless said this week that it has named Dr. John Davis to its board of directors. Davis is the founder an dprincipal of the Technology Advisors Group, a consulting firm, and has served as CTO of AT&T Communications Services/Bell Laboratories and Allied Riser Communications. Novatel develops wireless modems and products for connecting mobile devices to broadband and wireless networks.
posted on Friday, January 21, 2005(Full story)

InfoGenesis Goes Down Under
Santa Barbara-based InfoGenesis has signed the Melbourne Cricket Ground, the largest stadium in the Southern Hemisphere for its information technology solution. The stadium will use Infogenesis to manage its food and beverage point of sales transacations throughout the stadium. The software will allow the stadium to manage of all food and beverage operations in real time, allowing for enterprise-wide reporting in real-time. InfoGenesis was recently acquired by Warburg Pincus.
posted on Friday, January 21, 2005(Full story)

Arkeia Backs Up SQL Server
Carlsbad-based Arkeia has shipped a new back up plug-in for hot backing up Microsoft SQL Server data. The data backup company's new software allows users to back up their running Microsoft SQL Server instances without interrupting services Arkeia said that the new plug-in supports SQL Server 7, SQL Server 2000, and later versions on NT4, NT Enterprise, and Windows 2000/2003 Server. Arkeia is a developer of backup and restore software for Linux and other platforms.
posted on Friday, January 21, 2005(Full story)

FileNet Moves Into Email Archiving
Costa Mesa-based FileNet has moved into the email archiving software market this week, introducing a new email management software suite used to capture, organize, retrieve, and retain email content. The company's new FileNet Email Manager is targeted at regulatory compliance and archiving, allowing companies to manage email as a business record. The company said that its new software suite uses intelligent rules to decide which emails to archive, and does not blindly archive all emails, instead (More info...)
posted on Friday, January 21, 2005(Full story)

Activision Acquires Game Company
Santa Monica-based Activision said Thursday that it is acquiring Vicarious Visions, the game developer behind the Nintendo DS title Spider Man 2. Terms were not disclosed. Activision said that it will integrate Vicarious Vision's middleware technology and tools for game development into its own suite of development tools. Activision said that the 100 employees of Vicarious will become a wholly owned subsidiary of the firm.
posted on Friday, January 21, 2005(Full story)

Pfizer Buys Angiosyn for $527M
Pharmaceutical giant Pfizer has agreed to buy San Diego-based biopharmaceutical startup Angiosyn, in a deal worth $527M plus future royalties. The deal was announced late Thursday night. Angiosyn is a spinoff of the Scripps Research Institute, developing an experimental drug to treat macular degeneration. Pfizer said that the company would continue to develop Angiosyn's angiostatic agent to treat ophthalmic diseases and that will merge into a wholly owned subsidiary of Pfizer. Angiosyn is backed (More info...)
posted on Friday, January 21, 2005(Full story)